NO971604L - Orale sabeluzolsuspensjoner - Google Patents

Orale sabeluzolsuspensjoner

Info

Publication number
NO971604L
NO971604L NO971604A NO971604A NO971604L NO 971604 L NO971604 L NO 971604L NO 971604 A NO971604 A NO 971604A NO 971604 A NO971604 A NO 971604A NO 971604 L NO971604 L NO 971604L
Authority
NO
Norway
Prior art keywords
sabeluzole
oral
suspensions
suspension
preparation
Prior art date
Application number
NO971604A
Other languages
English (en)
Other versions
NO971604D0 (no
Inventor
Marc Karel Jozef Francois
Christine Frieda Augus Agemans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO971604D0 publication Critical patent/NO971604D0/no
Publication of NO971604L publication Critical patent/NO971604L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Dental Preparations (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

En vandig suspensjon for oral adminstrasjon omfattende sabeluzol og en farmasøytisk akseptabel bærer, hvilken suspensjon har en pH i området 8-10, samt fremstilling derav.
NO971604A 1994-10-14 1997-04-08 Orale sabeluzolsuspensjoner NO971604L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94202986 1994-10-14
PCT/EP1995/003966 WO1996011687A1 (en) 1994-10-14 1995-10-06 Sabeluzole oral suspensions

Publications (2)

Publication Number Publication Date
NO971604D0 NO971604D0 (no) 1997-04-08
NO971604L true NO971604L (no) 1997-04-08

Family

ID=8217278

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971604A NO971604L (no) 1994-10-14 1997-04-08 Orale sabeluzolsuspensjoner

Country Status (15)

Country Link
US (1) US5700814A (no)
EP (1) EP0785783A1 (no)
JP (1) JPH10511640A (no)
CN (1) CN1160348A (no)
AU (1) AU689663B2 (no)
FI (1) FI971534L (no)
HU (1) HUT77362A (no)
IL (1) IL115626A (no)
MX (1) MX9702506A (no)
NO (1) NO971604L (no)
NZ (1) NZ295132A (no)
RU (1) RU2141821C1 (no)
TR (1) TR199501263A2 (no)
WO (1) WO1996011687A1 (no)
ZA (1) ZA958687B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583072A (en) * 1995-06-30 1996-12-10 Siemens Components, Inc. Method of manufacturing a monolithic linear optocoupler
GB9930058D0 (en) 1999-12-20 2000-02-09 Novartis Ag Organic compounds
WO2003077842A2 (en) * 2002-03-12 2003-09-25 Bristol-Myers Squibb Company Palatable oral suspension and method
CA2539494C (en) * 2003-09-22 2011-12-06 Baxter International Inc. High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products
CA2580659C (en) * 2004-09-15 2013-02-26 Ivx Animal Health, Inc. Corticosteroid having low systemic absorption
US8263652B2 (en) 2007-10-31 2012-09-11 Sk Biopharmaceuticals Co., Ltd. Stabilized pediatric suspension of carisbamate
US20230247982A1 (en) * 2020-07-13 2023-08-10 University Of Cincinnati Improving Packed Red Blood Cell Storage with a High Viscosity Buffered Storage Solution

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361580A (en) * 1980-06-20 1982-11-30 The Upjohn Manufacturing Company Aluminum ibuprofen pharmaceutical suspensions
US4861785A (en) * 1984-12-03 1989-08-29 Janssen Pharmaceutica N.V. Benzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agents
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
WO1994025029A2 (en) * 1993-04-26 1994-11-10 Janssen Pharmaceutica N.V. Use of sabeluzole in chronic neurodegenerative diseases

Also Published As

Publication number Publication date
RU2141821C1 (ru) 1999-11-27
EP0785783A1 (en) 1997-07-30
JPH10511640A (ja) 1998-11-10
AU3840295A (en) 1996-05-06
AU689663B2 (en) 1998-04-02
NZ295132A (en) 1998-06-26
NO971604D0 (no) 1997-04-08
FI971534A0 (fi) 1997-04-11
HUT77362A (hu) 1998-03-30
FI971534A7 (fi) 1997-04-11
FI971534L (fi) 1997-04-11
US5700814A (en) 1997-12-23
MX9702506A (es) 1997-07-31
WO1996011687A1 (en) 1996-04-25
ZA958687B (en) 1997-04-14
IL115626A (en) 1999-09-22
CN1160348A (zh) 1997-09-24
IL115626A0 (en) 1996-01-19
TR199501263A2 (tr) 1996-06-21

Similar Documents

Publication Publication Date Title
MX9802383A (es) Derivados de pirimidina como antagonistas del receptor 5ht26.
NO307459B1 (no) Piperazinderivater, samt farmasøytiske preparater inneholdende slike
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
DE3882631D1 (de) Waessrige dispersionen.
DK1143967T3 (da) Anticonvulsive derivater egnede til behandling af Hortons hovedpine
CA2160447A1 (en) Amino(thio)ether derivatives
NO891663D0 (no) Sjampo med lav ph som inneholder climbazol.
TR199600697A2 (tr) Tasit gövdesi yapisi.
NL300214I1 (nl) Chinazolinederivaten.
SE9503143D0 (sv) New preparation
DK0742715T3 (da) Orale, væskeformige præparater indeholdende paroxetin-resinat
DE3874493D1 (de) Optischer positionssensor, den faraday-effekt benutzend.
MX9709146A (es) Compuestos novedosos, preparacion y uso de los mismos.
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
MX9206408A (es) Conjugados policiclicos.
MX9800408A (es) Sales de derivados de amidina y de inhibidor de ciclooxigenasa, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que los contienen.
ITTO910599A0 (it) Amplificatore,particolarmente amplificatore integrato.
HRP20010878B1 (en) Ziprasidone suspension
ATE91272T1 (de) Stabile, waessrige faellungskieselsaeuresuspension.
TR199700206A2 (xx) Floralkil- ve floralkoksi ikame edilmi� heterosiklik bradikinin-antagonistleri, bunlar�n imal edilmesine mahsus usul ve bunlar�n kullan�lmalar�.
MXPA03005221A (es) Composicion farmaceutica de dronedarona para administracion parenteral.
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
TR199600715A2 (tr) Kefalosforin türevleri.
DE60113659D1 (de) Orale zusammensetzung enthaltend 2'-hydroxypropiophenon
MX9702506A (es) Suspensiones orales de sabeluzol.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application